Your browser is no longer supported. Please, upgrade your browser.
Settings
DXCM DexCom, Inc. daily Stock Chart
DXCM [NASD]
DexCom, Inc.
Index- P/E121.73 EPS (ttm)1.15 Insider Own1.70% Shs Outstand89.57M Perf Week-2.47%
Market Cap12.50B Forward P/E- EPS next Y-0.02 Insider Trans-21.19% Shs Float87.03M Perf Month1.02%
Income100.30M PEG- EPS next Q-0.10 Inst Own- Short Float7.73% Perf Quarter40.12%
Sales832.50M P/S15.01 EPS this Y182.00% Inst Trans-9.72% Short Ratio6.51 Perf Half Y102.76%
Book/sh5.47 P/B25.50 EPS next Y96.00% ROA-0.60% Target Price129.68 Perf Year100.72%
Cash/sh6.77 P/C20.62 EPS next 5Y- ROE-1.30% 52W Range42.62 - 148.56 Perf YTD143.07%
Dividend- P/FCF233.99 EPS past 5Y23.00% ROI8.20% 52W High-6.10% Beta0.45
Dividend %- Quick Ratio4.60 Sales past 5Y48.40% Gross Margin66.40% 52W Low227.31% ATR4.27
Employees2290 Current Ratio4.90 Sales Q/Q42.10% Oper. Margin-2.90% RSI (14)56.28 Volatility2.99% 3.15%
OptionableYes Debt/Eq0.71 EPS Q/Q906.60% Profit Margin-0.60% Rel Volume1.46 Prev Close139.41
ShortableYes LT Debt/Eq0.71 EarningsAug 01 AMC Payout- Avg Volume1.03M Price139.50
Recom1.90 SMA20-2.04% SMA5011.42% SMA20063.80% Volume1,504,168 Change0.06%
Sep-12-18Upgrade Northland Capital Under Perform → Market Perform
Aug-02-18Reiterated Canaccord Genuity Buy $105 → $125
Jul-02-18Upgrade Raymond James Mkt Perform → Outperform
Jun-08-18Upgrade JP Morgan Neutral → Overweight
May-11-18Initiated BofA/Merrill Buy $100
May-03-18Reiterated Canaccord Genuity Buy $81 → $85
Apr-04-18Initiated Guggenheim Neutral
Apr-04-18Initiated Goldman Sell $57
Mar-23-18Upgrade Robert W. Baird Neutral → Outperform
Jan-04-18Downgrade Northland Capital Market Perform → Under Perform
Sep-28-17Reiterated Wedbush Outperform $85 → $76
Sep-28-17Downgrade Raymond James Outperform → Mkt Perform
Sep-28-17Downgrade Northland Capital Outperform → Market Perform
Sep-28-17Downgrade JP Morgan Overweight → Neutral
Sep-26-17Initiated Northland Capital Outperform $85
Sep-15-17Initiated Barclays Equal Weight $76
May-22-17Resumed Piper Jaffray Overweight
May-03-17Reiterated Canaccord Genuity Buy $95 → $90
Jan-03-17Downgrade Morgan Stanley Overweight → Equal-Weight $66
Dec-19-16Upgrade Oppenheimer Perform → Outperform
Sep-18-18 01:01PM  DexCom Inc (NASDAQ:DXCM): Are Analysts Optimistic? Simply Wall St.
Sep-14-18 01:05PM  10 Boring Stocks Growing Like Weeds InvestorPlace
Sep-03-18 11:43AM  Why DexCom Soared 51.8% in August Motley Fool
Aug-28-18 08:47AM  Here's Why You Should Hold On to DexCom (DXCM) Stock Now Zacks
Aug-23-18 08:23AM  The Daily Biotech Pulse: Novartis Breast Cancer Trial Meets Endpoint, Medpace's Offering, Dexcom Buys TypeZero Benzinga
Aug-22-18 04:05PM  Dexcom Acquires TypeZero Technologies Business Wire
08:00AM  DexCom Announces Upcoming Conference Presentation Business Wire
Aug-14-18 01:40AM  Edited Transcript of DXCM earnings conference call or presentation 1-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-11-18 07:00AM  Sensors to Smartphones Bring Patent Wars to Diabetes Monitoring Bloomberg
Aug-04-18 08:31AM  3 Stocks That Soared 20% or More This Week -- Which Are Still Buys? Motley Fool
Aug-03-18 09:50AM  DexCom (DXCM) Beats Q2 Earnings Estimates, Raises '18 View Zacks
08:00AM  Todays Research Reports on Stocks to Watch: DexCom and Exact Sciences ACCESSWIRE
Aug-02-18 02:18PM  DexCom Stock Skyrockets on Q2 Earnings Beat InvestorPlace +30.65%
02:06PM  Dexcom stock surges 30% on better-than-expected revenue results MarketWatch
11:59AM  Why Dexcom Is Soaring Today Motley Fool
08:54AM  The Daily Biotech Pulse: Denali's Parkinson's Candidate Clears Early-Stage Trials, Dexcom's Strong Quarter Benzinga
08:45AM  What DexCom Just Said About Its Future Motley Fool
08:44AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga
Aug-01-18 06:30PM  DexCom (DXCM) Reports Q2 Loss, Tops Revenue Estimates Zacks
05:21PM  DexCom: 2Q Earnings Snapshot Associated Press
04:10PM  DexCom Executive Chairman and Director Terry Gregg Retires Business Wire
04:01PM  DexCom Reports Second Quarter 2018 Financial Results Business Wire
02:48PM  5 Connected Devices Stocks for a High-Tech Portfolio InvestorPlace
Jul-25-18 08:00AM  DexCom Announces Upcoming Conference Presentation Business Wire
Jul-20-18 10:02AM  The Three Bullish Charts of DexCom TheStreet.com
Jul-16-18 09:30AM  Top Analysts Say Gamble On These 3 Ace Stocks TheStreet.com
Jul-12-18 07:25AM  Free Research Reports on DexCom and Three More Medical Research Stocks ACCESSWIRE
Jul-11-18 08:30AM  3 Top Growth Stocks to Buy in July Motley Fool
Jul-06-18 12:59PM  Top Stocks Set to Disrupt the Diabetes Market Motley Fool
Jul-03-18 08:00AM  DexCom Schedules Second Quarter 2018 Earnings Release and Conference Call for August 1, 2018 at 4:30 p.m. Eastern Time. Business Wire
06:34AM  3 Best Diabetes Stocks of 2018 So Far Motley Fool
Jun-22-18 12:59PM  Big News Sends Tandem Diabetes Soaring 10.2% Today Motley Fool
Jun-20-18 04:22PM  Dexcom plans 300 hires this year, including 100 this week American City Business Journals
10:18AM  Why the Outlook for Fitbit Stock Is Positive in Any Scenario InvestorPlace
Jun-14-18 06:48PM  Cramer's lightning round: Skechers is in the 'penalty box' until its next earnings report CNBC
01:04PM  Fitbit Inc May Still Have 30% Upside Despite Massive Rally InvestorPlace
07:50AM  Consolidated Research: 2018 Summary Expectations for Humana, DexCom, Royal Dutch Shell, First Connecticut, Bank of America, and Equifax Fundamental Analysis, Key Performance Indications GlobeNewswire
Jun-13-18 07:24PM  DexCom Stock History Motley Fool
Jun-12-18 07:00AM  Dexcom G6® CGM System Receives CE Mark Business Wire
Jun-11-18 06:28PM  Dexcom G5 Continuous Glucose Monitoring System Now Available on Mobile, Smart Devices for Medicare Patients with Diabetes Business Wire
Jun-08-18 03:59PM  Diabetes 'technological wave' has too much upside to ignore: JP Morgan CNBC
Jun-05-18 08:35AM  Federal Court Judge Awards AgaMatrix Attorneys' Fees While Admonishing Dexcom for "Bad Faith" Lawsuit PR Newswire
Jun-04-18 09:22AM  Portland-area medical device maker wins another round in federal court American City Business Journals
07:10AM  Stock Performance Review on Exact Sciences and Three Other Medical Research Stocks ACCESSWIRE
Jun-01-18 09:15AM  DexCom (DXCM) Up 17.7% Since Earnings Report: Can It Continue? Zacks
May-28-18 10:40AM  3 Innovative Medical Technology Companies Shaking Up the Diabetes Market Motley Fool
May-25-18 03:57PM  3 Top Stocks That Aren't on Wall Street's Radar Motley Fool
12:40PM  Five Top MedTech Stocks in Diabetes Motley Fool
May-17-18 08:00AM  DexCom Announces Upcoming Conference Presentation Business Wire
May-12-18 09:00AM  Dexcom's newest diabetes device can read your blood sugar without any blood, and it's a life-changer CNBC
May-04-18 09:19AM  DexCom (DXCM) Meets Q1 Earnings Estimates, Raises '18 View Zacks
May-03-18 10:05PM  Edited Transcript of DXCM earnings conference call or presentation 2-May-18 8:30pm GMT Thomson Reuters StreetEvents +12.78%
10:49AM  Here's Why DexCom Is Surging Today Motley Fool
May-02-18 05:33PM  DexCom: 1Q Earnings Snapshot Associated Press
04:01PM  DexCom Reports First Quarter 2018 Financial Results Business Wire
Apr-17-18 07:30AM  New Research Coverage Highlights DexCom, Equinix, Fitbit, Gilead Sciences, Humana, and Microsoft Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Apr-10-18 04:58PM  Edited Transcript of DXCM presentation 6-Mar-17 9:00pm GMT Thomson Reuters StreetEvents
07:30AM  Free Research Report as DexComs Quarterly Revenues Surged 29%; Turned Profitable Y-O-Y ACCESSWIRE
Apr-04-18 03:35PM  Here's Why Senseonics Holdings Inc. Is Rising Today Motley Fool
08:00AM  DexCom Schedules First Quarter 2018 Earnings Release and Conference Call for May 2, 2018 at 4:30 p.m. Eastern Time. Business Wire
Mar-29-18 07:00PM  Cramer's lightning round: CVS' management is no good at t... CNBC Videos
06:50PM  Cramer's lightning round: CVS' management is no good at telling their story CNBC
Mar-28-18 10:14AM  DexCom (DXCM) Gets FDA Approval for G6 CGM Monitoring System Zacks
Mar-27-18 04:45PM  FDA Authorizes Marketing of the New Dexcom G6® CGM Eliminating Need for Fingerstick Blood Testing for People with Diabetes Business Wire
04:12PM  FDA approves DexCom's glucose monitoring system Reuters
Mar-26-18 08:30AM  Todays Research Reports on Trending Tickers: DexCom and Solid Biosciences ACCESSWIRE
Mar-08-18 01:36PM  WaveForm Technologies Receives Favorable Decision on Critical Glucose Monitoring Patents PR Newswire
Mar-01-18 09:28AM  DexCom (DXCM) Surpasses Earnings & Revenue Estimates in Q4 Zacks
Feb-28-18 04:25PM  Edited Transcript of DXCM earnings conference call or presentation 27-Feb-18 9:30pm GMT Thomson Reuters StreetEvents
Feb-27-18 05:31PM  DexCom reports 4Q loss Associated Press
04:01PM  DexCom Reports Record Fourth Quarter and Fiscal Year 2017 Financial Results Business Wire
12:50PM  DexCom, Inc. to Host Earnings Call ACCESSWIRE
12:29PM  DexCom Q4 Earnings Preview Benzinga
09:13AM  This Is Not the End of the World for Fitbit Inc Stock InvestorPlace
08:15AM  What Does DexCom Incs (NASDAQ:DXCM) Share Price Indicate? Simply Wall St.
06:09AM  Fitbit Shares Crater 16% After Brutal Guidance TheStreet.com
Feb-26-18 09:25AM  George Soros Just Bought These 2 Biotech Stocks. Should You? Motley Fool
08:27AM  Patterson Companies (PDCO) Q3 Earnings: What's in Store? Zacks
Feb-23-18 08:53AM  Why DexCom (DXCM) Might Surprise This Earnings Season Zacks
Feb-20-18 03:30AM  New Study Demonstrates that DexCom CGM Significantly Reduces Hypoglycaemia in People with Type 1 Diabetes on MDI PR Newswire
Feb-19-18 12:31PM  Is DexCom Incs (NASDAQ:DXCM) Balance Sheet Strong Enough To Weather A Storm? Simply Wall St.
Feb-12-18 08:00AM  DexCom Announces Upcoming Conference Presentations Business Wire
Feb-02-18 08:25AM  Investor Expectations to Drive Momentum within Valero Energy Partners LP, Middlesex Water, ForeScout Technologies, Calithera Biosciences, eBay, and DexCom Discovering Underlying Factors of Influence GlobeNewswire
Feb-01-18 08:00AM  DexCom Schedules Fourth Quarter and Full Year 2017 Earnings Release and Conference Call for February 27, 2018 at 4:30 p.m. Eastern Time. Business Wire
Jan-11-18 08:02AM  See what the IHS Markit Score report has to say about Dexcom Inc. Markit
Jan-10-18 10:30AM  UnitedHealthcare and Dexcom Bring Wearable Technology Solution, One-on-One Coaching to People Battling Type 2 Diabetes Business Wire +7.33%
08:02AM  See what the IHS Markit Score report has to say about Dexcom Inc. Markit
07:38AM  DexCom Estimates Strong Revenue Figures for Q4 and 2017 Zacks
Jan-09-18 01:12PM  Fitbit for Kids? FIT Considering Smartwatch for Children InvestorPlace
Jan-08-18 04:05PM  DexCom Reports Record Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2017 and Provides Initial 2018 Outlook Business Wire
10:31AM  Fibit Inc Invests in Blood Glucose Monitoring Startup InvestorPlace
Jan-05-18 09:14AM  To catch Apple, Fitbit invests in a start-up making tiny device to track blood sugar for diabetics CNBC
Jan-04-18 12:15PM  Medicare to cover new glucose monitor, giving Abbott an edge over rival Dexcom CNBC -10.04%
12:11PM  This News Explains Why DexCom Is Dropping Today Motley Fool
09:05AM  CMS to cover Abbott's glucose monitoring device Reuters
Dec-26-17 09:20AM  The Zacks Analyst Blog Highlights: Bio-Rad Laboratories, Mazor Robotics, Tactile Systems, Eli Lilly and DexCom Zacks
Dec-22-17 02:33PM  4 MedTech Stocks to Explode in 2018 Zacks
Dec-20-17 08:49AM  DexCom (DXCM) Banks on Collaborations, Competition Rife Zacks
Dec-12-17 08:00AM  DexCom Announces Upcoming Conference Presentation Business Wire
Dec-08-17 12:42PM  ETFs with exposure to DexCom, Inc. : December 8, 2017 Capital Cube
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers. Its products include DexCom G5 mobile continuous glucose monitoring system to communicate directly to patient's mobile device; DexCom G4 PLATINUM system for continuous use by adults with diabetes; and DexCom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC to develop a series of next-generation CGM products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Balo Andrew KEVP, Reg. Strategy, ClinicalSep 14Sale145.175,000725,85188,105Sep 18 07:54 PM
Leach Jacob StevenSVP, Research & DevelopmentSep 12Option Exercise5.9215,00088,800109,284Sep 14 04:35 PM
Blackford Quentin S.EVP, CFO, PFO & PAOSep 11Sale147.048,4401,241,02887,131Sep 13 09:48 PM
SAYER KEVIN RPresident, CEO & ChairmanSep 10Option Exercise4.5811,16151,117346,332Sep 12 09:17 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerSep 10Sale143.765,483788,21066,804Sep 12 09:22 PM
MOY JEFFREYSVP, OperationsSep 10Sale143.355,736822,25616,711Sep 12 09:22 PM
MOY JEFFREYSVP, OperationsSep 10Sale143.764,594660,41163,920Sep 12 09:22 PM
Murphy Patrick MichaelVP, Legal Aff & Chf Compl OfcrSep 10Sale143.692,372340,82531,308Sep 12 09:20 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Sep 10Sale143.765,483788,210116,974Sep 12 09:21 PM
Balo Andrew KEVP, Reg. Strategy, ClinicalSep 10Sale143.765,587803,16093,105Sep 12 09:21 PM
ACE HEATHER SSVP Human ResourcesSep 10Sale143.761,832263,36069,339Sep 12 09:19 PM
Leach Jacob StevenSVP, Research & DevelopmentSep 10Sale143.764,614663,28694,284Sep 12 09:20 PM
Abbey DonaldEVP, Quality & Regulatory AfrsSep 10Sale143.762,303331,06898,639Sep 12 09:19 PM
Blackford Quentin S.EVP, CFO, PFO & PAOSep 10Sale143.767,1491,027,70695,571Sep 12 09:18 PM
SAYER KEVIN RPresident, CEO & ChairmanSep 10Sale143.6225,4953,661,573320,837Sep 12 09:17 PM
Leach Jacob StevenSVP, Research & DevelopmentAug 24Option Exercise4.5220,57792,941109,455Aug 28 06:58 PM
ALTMAN STEVEN RDirectorAug 24Sale136.475,000682,3590Aug 28 08:32 PM
FOLETTA MARK GDirectorAug 24Sale137.501,000137,50317,095Aug 28 07:01 PM
Leach Jacob StevenSVP, Research & DevelopmentAug 24Sale138.3220,5772,846,15598,878Aug 28 06:58 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Aug 23Sale139.963,114435,843122,457Aug 27 05:20 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerAug 23Sale140.032,584361,8330Aug 27 05:20 PM
Balo Andrew KEVP, Reg. Strategy, ClinicalAug 14Sale124.255,000621,25398,567Aug 16 06:08 PM
SAYER KEVIN RPresident, CEO & ChairmanAug 13Option Exercise4.5811,16151,117346,332Aug 15 05:15 PM
SAYER KEVIN RPresident, CEO & ChairmanAug 13Sale123.2211,1611,375,211335,171Aug 15 05:15 PM
Murphy Patrick MichaelVP, Legal Aff & Chf Compl OfcrAug 10Sale124.1812,5001,552,31033,680Aug 14 08:32 PM
AUGUSTINOS NICHOLASDirectorAug 06Sale121.773,230393,30114,362Aug 08 08:33 PM
AUGUSTINOS NICHOLASDirectorAug 06Sale121.189,0701,099,0807,802Aug 08 08:33 PM
MOY JEFFREYSVP, OperationsAug 01Sale94.135,831548,8725,061Aug 03 04:50 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Jul 25Sale101.913,114317,335125,571Jul 27 05:09 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerJul 23Sale102.482,581264,5131,067Jul 25 07:54 PM
GREGG TERRANCE HExecutive ChairmanJul 16Sale99.5610,000995,56150,882Jul 18 05:50 PM
Balo Andrew KEVP, Reg. Strategy, ClinicalJul 16Sale99.565,000497,816103,567Jul 18 05:50 PM
SAYER KEVIN RPresident & CEOJul 09Sale99.7914,2191,418,856335,171Jul 11 09:07 PM
MOY JEFFREYSVP, OperationsJun 28Sale92.4859,1935,474,29710,892Jul 02 08:51 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerJun 25Sale98.582,581254,4313,648Jun 26 08:26 PM
GREGG TERRANCE HExecutive ChairmanJun 15Sale97.8110,000978,096882Jun 19 08:37 PM
TOPOL ERICDirectorJun 12Sale100.1020,0002,001,99884,562Jun 13 08:19 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerMay 23Sale86.002,581221,9636,229May 25 07:52 PM
GREGG TERRANCE HExecutive ChairmanMay 15Sale85.9010,000858,974882May 17 06:49 PM
SKYLER JAY SDirectorMay 14Option Exercise4.5830,000137,40052,257May 16 08:00 PM
SKYLER JAY SDirectorMay 14Sale88.0030,0002,640,00022,257May 16 08:00 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.May 10Option Exercise7.632,85521,784128,685May 11 08:03 PM
SAYER KEVIN RPresident & CEOMay 09Option Exercise7.6331,464240,070366,635May 10 07:54 PM
Leach Jacob StevenSVP, Research & DevelopmentMay 09Option Exercise9.728,74585,017107,420May 10 07:54 PM
Leach Jacob StevenSVP, Research & DevelopmentMay 09Sale84.778,745741,32898,878May 10 07:54 PM
SAYER KEVIN RPresident & CEOMay 09Sale84.3717,2451,454,992349,390May 10 07:54 PM
SKYLER JAY SDirectorMay 08Option Exercise7.6331,464240,07053,721May 09 08:22 PM
Leach Jacob StevenSVP, Research & DevelopmentMay 08Option Exercise3.191,9236,134100,801May 10 07:54 PM
Leach Jacob StevenSVP, Research & DevelopmentMay 08Sale85.152,500212,87447,600May 10 07:54 PM
Leach Jacob StevenSVP, Research & DevelopmentMay 08Sale84.951,923163,36698,878May 10 07:54 PM
SKYLER JAY SDirectorMay 08Sale85.1131,4642,678,02422,257May 09 08:22 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerApr 23Sale73.092,581188,6498,810Apr 25 07:33 PM
GREGG TERRANCE HExecutive ChairmanApr 16Sale73.0410,000730,414882Apr 18 07:24 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerMar 23Sale68.442,581176,64311,391Mar 27 06:54 PM
GREGG TERRANCE HExecutive ChairmanMar 15Sale65.5110,000655,12210,882Mar 19 08:08 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerFeb 23Sale56.321,63892,25213,972Feb 27 05:32 PM
GREGG TERRANCE HExecutive ChairmanFeb 15Sale55.9110,000559,09520,882Feb 20 08:14 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerJan 23Sale54.671,63589,38415,610Jan 25 07:44 PM
GREGG TERRANCE HExecutive ChairmanJan 16Sale56.8610,000568,58830,882Jan 18 08:21 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerDec 26Sale56.391,63592,20417,245Dec 28 04:25 PM
SAYER KEVIN RPresident & CEODec 12Sale58.856,000353,092280,826Dec 13 05:07 PM
Balo Andrew KEVP, Reg. Strategy, ClinicalDec 11Sale61.233,245198,69179,547Dec 13 05:06 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Nov 29Sale60.122,900174,34096,426Nov 30 08:57 PM
Balo Andrew KEVP, Reg. Strategy, ClinicalNov 29Sale60.006,490389,40082,792Nov 30 08:56 PM
FOLETTA MARK GDirectorNov 27Sale54.952,500137,38613,143Nov 29 06:24 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerNov 24Sale55.531,63590,78818,880Nov 27 05:31 PM
KAHN BARBARADirectorNov 20Sale54.583,000163,72723,095Nov 20 07:20 PM
SAYER KEVIN RPresident & CEONov 20Sale55.0012,000660,000286,826Nov 21 05:09 PM
ALTMAN STEVEN RDirectorNov 07Buy50.0125,0001,250,25058,502Nov 09 08:19 PM
ALTMAN STEVEN RDirectorNov 06Buy49.6110,000496,10033,502Nov 08 08:44 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerOct 23Sale44.821,63573,27420,515Oct 25 05:36 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Sep 25Sale69.811,450101,21999,326Sep 27 07:49 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerSep 25Sale69.771,635114,08022,150Sep 27 07:49 PM